No FDA warning label for doxazosin as yet

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 856卷 / 1期
关键词：
Public Health; Adverse Effect; Heart Failure; Cardiovascular Disease; Congestive Heart Failure;
D O I：
10.2165/00128415-200108560-00003
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [1] FDA lifts olestra warning label
    Walsh, K
    CHEMICAL WEEK, 2003, 165 (28) : 42 - 42
  • [2] FDA adds warning to baricitinib label: hypersensitivity
    Reactions Weekly, 2020, 1814 (1) : 3 - 3
  • [3] FDA GROUP URGES SUX LABEL REDUCED TO WARNING
    MORELL, RC
    JOURNAL OF CLINICAL MONITORING, 1995, 11 (02): : 141 - 143
  • [4] Drug maker found liable despite FDA warning label
    Nature, 2009, 458 (7235) : 137 - 137
  • [5] Examination of Voluntary Compliance with New FDA Cigar Warning Label Requirements
    Wackowski, Olivia A.
    Kurti, Marin
    Schroth, Kevin R. J.
    Delnevo, Cristine D.
    TOBACCO REGULATORY SCIENCE, 2020, 6 (06) : 379 - 383
  • [6] An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
    Chaloupka, Frank J.
    Warner, Kenneth E.
    Acemoglu, Daron
    Gruber, Jonathan
    Laux, Fritz
    Max, Wendy
    Newhouse, Joseph
    Schelling, Thomas
    Sindelar, Jody
    TOBACCO CONTROL, 2015, 24 (02) : 112 - 119
  • [7] Children's Exposure to Testosterone Gel Spurs FDA to Order Boxed Label Warning
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (23): : 2428 - 2428
  • [8] FDA VARICELLA WARNING
    TINKELMAN, DG
    PEDIATRICS, 1992, 90 (03) : 479 - 480
  • [9] FDA rosiglitazone warning
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (24): : 2858 - 2858
  • [10] FDA Warning for Etravirine
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (11) : 1050 - 1050
12345